Effect of novel penetration enhancers on the transdermal delivery of hydrocortisone: An in vitro species comparison

Journal of Controlled Release

Volumn 45, Issue 2, 1997, Pages 199-206

  Fuhrman Jr , L C ^a   Michniak, B B ^a   Behl, C R ^a   Malick, A W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Azone; Enhancer; Hairless mouse skin; Hairless rat skin; Human cadaver skin; Hydrocortisone; Transdermal

Indexed keywords

1 DODECYL 2 PIPERIDONE; 1 DODECYL 2 PYRROLIDINONE; HYDROCORTISONE; LAUROCAPRAM; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM;

EID: 0031049221     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01573-8     Document Type: Article

References (32)

1. B.W. Barry, Dermatological Formulations-Percutaneous Absorption, Vol. 18, Marcel Dekker, New York, NY, 1983.
2. R.L. Bronaugh and H.I. Mailbach, In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications, CRC Press, Boca Raton, FL, 1991.
3. B.W. Barry, Action of skin penetration enhancers-the lipid-protein-partitioning theory, Int. J. Cosmet. Sci., 10 (1988) 281-289.
4. M.L. Williams and P.M. Elias, The extracellular matrix of stratum corneum: role of lipids in normal pathological function, Crit. Rev. Ther. Drug Carrier Syst., 3 (1987) 535-546.
5. G.M. Golden, D.B. Guzek, R.R. Harris, J.E. Mckie, and R.O. Potts, Lipid thermotropic transitions in human stratum corneum, J. Invest. Dermatol., 91 (1986) 323-327.
6. B.B. Michniak, M.R. Player, J.M. Chapman and J.W. Sowell, In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. I, Int. J. Pharm., 91 (1993), 85-93.
7. B.B. Michniak, M.R. Player, L.C. Fuhrman, C.A. Christensen, J.M. Chapman, and J.W. Sowell, In vitro evalutaion of a series of Azone analogs as dermal penetration enhancers. III. Acyclic amides, Int. J. Pharm., 110 (1994) 231-239.
8. B.B. Michniak, M.R. Player, D.A. Godwin, C.A. Phillips and, J.W. Sowell, In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. IV. Amines, Int. J. Pharm., 116 (1995) 201-209.
9. B.B. Michniak, M.R. Player, D.A. Godwin and J.W. Sowell, Investigation of enhancer structure activity relationships in congeners of 2-(1-nonyl)-1,3- dioxolanes, Drug Deliv., 2 (1995), 117-122.
10. B.B. Michniak, M.R. Player, J.M. Chapman and J.W. Sowell, Azone analogs as permeation enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention, J. Control. Rel., 32 (1994) 147-54.
11. S. Bolton, Pharmaceutical Statistics: Practical and Clinical Applications, Marcel Dekker, New York, NY, 1990.
12. V. Rajadhyaksha, Vehicle composition containg 1-substituted azacycloheptan-2- ones, U.S. Patent 3,989,816, 1975 (filed).
13. V. Rajadhyaksha, J. Peck, G. Minakanian, Method of synthesis of 1- dodecylazacycloheptan-2-one, U.S. Patent 4,422,970, 1982 (filed).
14. G. Minaskanian, J. Peck, Compositions comprising 1-substituted azacycloalkenes, U.S. Patent 4,755,535, 1988.
15. V. Rajadhyaksha, Penetration enhancers for transdermal drug delivery of systemic agents, U.S. Patent 4,562,075, 1985.
16. B.B. Michniak, M.R. Player, J.M. Chapman, and J.W. Sowell, Azone analogs as permeation enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention, J. Control. Release, 32 (1994) 147-54.
17. H. Sasaki, M. Kojima, Y. Mon, J. Nakamura and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on transdermal drug delivery I, Int. J. Pharm., 44 (1988) 15-24.
18. H. Sasaki, M. Kojima, Y. Mori, J. Nakamura, and J. Shibasaki, Enhancing effect of pyrrolidone derivatives on transdrmal penetration of 5-fluorouracil, triamcinolone acetate, indomethacin, and flubiprofen, J. Pharm. Sci., 80 (1991) 533-538.
19. K.R. Brain and K.A. Walters, Molecular modeling of skin permeation enhancement by chemical agents, in: K.A. Walters and J. Hadgraft (Eds.), Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, NY, 1993, pp. 389-416.
20. P.W. Wertz and D.T. Downing, ω-Hydroxyacid derivatives in the epidermis of several mammilian species, Comp. Biochem. Physiol. B., B93 (1989) 265-269.
21. J. Bouwstra, G. Gooris and J. van der Speck, Structural investigations of human stratum corneum by small angle x-ray scattering, J. Invest. Dermatol., 97 (1991) 1005-1010.
22. C.R. Behl, A general method for assessing skin permeation enhancement mechanisms and optimization, In D. Hsieh (Eds.), Drug Permeation Enhancement. Marcel Dekker, New York, NY, 1994, pp. 107-142.
23. J. Crank, The Mathematics of Diffusion, 2nd edn., Oxford University Press, London, England, 1975.
24. O. Wong, J. Huntington, T. Nishihata and J. Rytting, New alkyl N,N-dialkyl-substituted amino acetates as transdermal penetration enhancers, Pharm. Res., 6 (4) (1989) 286-295.
25. B.J. Aungst, Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants, Pharm. Res., 6 (3) (1989) 244-247.
26. B.J. Aungst, J.A. Blake, N.J. Rogers, and M.A. Hussain, Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles, J. Pharm. Sci., 79 (12) (1990) 1072-1076.
27. T.K. Ghosh and T.K. Banga, Methods of enhancement of transdermal drug delivery. Part I, physical and biochemical approaches, Pharm. Technol., 17 (1993) 72-85.
28. L.C. Fuhrman, B.B. Michniak, D.A. Godwin, A.W. Malick, C.R. Behl, Percutaneous absorption enhancement of hydrocortisone in hairless rat, Presented at 2nd International Conference on Pharmaceutical Sciences and Technology, East Brunswick, NJ, 1995.
29. C.M. Samour, L.G. Donamura, S. Daskelakis, B.S. Fulton, J.P. Marty, A.M. Dervault, J.F. Chanez, and O. Doucet, SEPAs - a new class of percutaneous absorption enhancers. Proc. Int. Symp. Control. Release Bioactive Mater., 16 (1989) 183-184.
30. J.P. Marty, H. Hagar, S. Khalil, C.M. Samour, In vitro/in vivo comparative effects of 2-n-nonyl dioxolane (SEPA-I) on indomethacin percutaneous absorption enhancement, Proc. Int. Symp. Control. Release Bioactive Mater., 17 (1990) 415-416.
31. C. Samour and S. Daskalakis, Percutaneous absorption enhancers, composition containing same and method of use. U.S. Patent 4,861,764, 1989.
32. R. Gyurik, S. Krauser, E. Gauthier, C. Reppucci, In vitro percutaneous absorption enhancement of econazole, Proc. Predict. Percut. Penet., 4a (1995) 36.